Behind the Lab
Delve behind the lab to see how our Retinal Health scientists are spearheading research into novel therapeutics to treat retinopathies.
Szukaj
Aftopor®/Aftovaxpur®/Aftovax®/Aftobov®Oleosa/Aftovaxpur®Doe
FMD vaccines with highly potent and purified antigens (Aftopor®, Aftovaxpur®, Aftobov® Oleosa) allow differentiation between infected and vaccinated animals for endemic or emergency situations.
We’re All In
Watch our video to learn about our approach to innovation and partnerships
View from Both Sides of the Table
Stawiamy na zarządzanie aliansami
Nota metodologiczna do Raportu Przejrzystości - Boehringer Ingelheim Sp. z o.o.
Our Partnering Culture
We embrace the power of partnerships and alliances to find even more breakthrough therapies that change lives.
Światowy Dzień Chorób Rzadkich 2021
Rzadkie, ale nie zapomniane: dlaczego wsparcie medyczne dla około 30 milionów osób w UE cierpiących na choroby rzadkie1 jest nie do przecenienia
SIRPα Cancer Immunology Research
Boehringer Ingelheim scientists are investigating a new target in the innate immune system - signal-regulating protein alpha or SIRPα.
Nerandomilast osiągnął pierwszorzędowy punkt końcowy w badaniu FIBRONEER™-IPF
Nerandomilast osiągnął pierwszorzędowy punkt końcowy w badaniu FIBRONEER™-IPF
World Recycling Day: Closing the Loop
Transitioning the economy from a linear to a circular approach herculean task – but also an innovation that carries huge potential
Retinal health
We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in Retinal Health.
Contact Us
Contact our partnering team to discuss your project and learn more about how we can work together.
Covid19 relief program Ghana Cowtribe parasiticides
Boehringer Ingelheim and Cowtribe are kicking off a vital relief initiative in Ghana.
Informacja o ochronie danych w przypadku monitoringu wizyjnego
Informacja o ochronie danych na stronie internetowej
Methodological Note to the Transparency Report of Boehringer Ingelheim Sp. z o.o.
Infarma (raport przejrzystości 2022) PL
Infarma (raport przejrzystości 2022) ENG
Spiolto Respimat_ChPL
Spiolto Respimat_Ulotka_15.12.2022
Świadomy pacjent oraz bezpieczne stosowanie leków
Be green Japan
Boehringer Ingelheim's Yamagata site is gradually switching to a more sustainable energy supply.
Retinal Health Research
Read about our holistic approach to retinal health research.
Odpowiedzialność, Zwinność, Intrapreneurship
Jak pracujemy razem
A Clear Vision
Take a tour of our journey into Retinal Health through this interactive infographic or descriptive audio recording, and learn how we aim to preserve or restore vision in people with retinal diseases.